로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > Integrin alpha 5 beta 1

Integrin alpha 5 beta 1

요약

Name:Integrin alpha-5/beta-1
Target Synonym:Integrin alpha5beta1
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Approved

제품 리스트 구매

일부의 생물활성 데이터

IT1-H82Wa-SPR
Human_FcRn_Heterodimer_Protein_SPR

Biotinylated Human ITGA5&ITGB1 Heterodimer Protein, His,Avitag&Tag Free (Cat. No. IT1-H82Wa) captured on Biotin CAP-Series S Sensor Chip can bind Human Fibronectin with an affinity constant of 4.4 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

IT1-H82Wa-ELISA
Biotinylated Human ITGA5&ITGB1 Heterodimer Protein, His,Avitag&Tag FreeBiotinylated Human ITGA5&ITGB1 Heterodimer Protein, His,Avitag&Tag Free (Cat. No. IT1-H82Wa) ELISA bioactivity

Immobilized Recombinant Human Fibronectin at 2 μg/mL (100 μL/well) can bind Biotinylated Human ITGA5&ITGB1 Heterodimer Protein, His,Avitag&Tag Free (Cat. No. IT1-H82Wa) with a linear range of 1-16 ng/mL (QC tested).

Synonym Name

Integrin alpha 5 beta 1,ITGA5&ITGB1

Background

Integrin alpha 5 beta 1 / Integrin α5β1, which is a major cellular receptor for the extracellular matrix protein fibronectin and plays a fundamental role during mammalian development., is composed of α5 (ITGA5/CD49e) and β1 (ITGB1/CD29) subunits. Integrins are adhesion receptors that transmit bidirectional signals across the plasma membrane. The Integrin alpha 5 beta 1 and its primary extracellular matrix ligand fibronectin (Fn) are of great biological importance.

Clinical and Translational Updates

공개 약품 정보

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Recombinant human endostatin (Simcere) YH-16 Approved Jiangsu Simcere Pharmaceutical Co Ltd Endostar, 恩度, Endu Mainland China Carcinoma, Non-Small-Cell Lung Shandong Simcere Bio-Pharmaceutical Co Ltd 2005-09-12 Head and Neck Neoplasms; Esophageal Neoplasms; Ascites; Osteosarcoma; Nasopharyngeal Carcinoma; Brain metastases; Pleural Effusion, Malignant; Carcinoma, Non-Small-Cell Lung Details

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
Risuteganib ALG-1001; AM011; AM-011(Allegro Ophthalmics) Phase 1 Clinical Allegro Ophthalmics Llc Diabetic macular oedema; Geographic Atrophy; Macular Degeneration; Diabetic Retinopathy Details
Pegylated recombinant human endostatin (Tsinghua University) M-2ES; CRB-0401 Phase 1 Clinical Tsinghua University, Beijing Protgen Biotechnology Development Co Ltd, Beijing Proji Pharmaceutical Technology Co Ltd Solid tumours; Pancreatic Neoplasms; Neoplasms; Carcinoma, Non-Small-Cell Lung Details
VAX-014 VAX-014 Phase 1 Clinical Vaxiion Therapeutics Llc Solid tumours Details

This web search service is supported by Google Inc.

totop